Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
falciparum malaria protein 11 + AS02A
- Development stage
- Unknown
- Lead developer
- Walter Reed Army Institute of Research
- Modality
- Recombinant Proteins and Enzymes, Vaccines & Immunotherapeutics
- Administration
- Intramuscular
01
Overview
Falciparum malaria protein 11 (FMP011) + AS02A is an experimental vaccine candidate for the prevention of *Plasmodium falciparum* malaria. FMP011 is a recombinant protein consisting of a 54-kDa, 456-amino-acid polypeptide derived from the N-terminal region of the *P. falciparum* apical membrane antigen-1 (AMA1), which plays a key role in erythrocyte invasion by the parasite[5]. The vaccine formulation includes the adjuvant system AS02A, designed to enhance immune responses. In clinical studies, this combination has been shown to induce strong antibody and cellular immune responses against AMA1 but did not prevent parasitemia following controlled human malaria infection[4][5]. The primary indication is for prophylaxis against *P. falciparum* malaria.
- Other names
- FMP011 + AS02Arecombinant Plasmodium falciparum protein 11 with AS02A adjuvant
02
Targets
AMA1 (Apical membrane antigen 1)
Beyond the preview
Go deeper on falciparum malaria protein 11 + AS02A.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on falciparum malaria protein 11 + AS02A.